Webcasts & Presentations

Neurocrine Biosciences’ management team participates in industry conferences providing presentations on company updates and progress on research and development activities. The company conducts webcasts and conference calls for these conferences and provides financial highlights and company news updates during regularly scheduled conference calls. Webcast replays are typically available up to 30 days following any event. For questions or information on current or future webcasts and conference calls contact ir@neurocrine.com.

May 7, 2024

Neurocrine Biosciences to Present at the BofA Securities 2024 Health Care Conference

SAN DIEGO, May 7, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) will present at the BofA Securities 2024 Health Care Conference at 11:20 a.m. Pacific Time (2:20 p.m. Eastern Time) on Tuesday May 14, 2024 in Las Vegas. Kevin Gorman, Chief Executive Officer, Matt Abernethy, Chief Financial Officer, and Kyle Gano, Chief Business Development and Strategy Officer, will present at the conference.

OPEN WEBCAST

April 10, 2024

Neurocrine Biosciences Announces Conference Call and Webcast of First Quarter 2024 Financial Results

SAN DIEGO, Apr. 10, 2024 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that it has scheduled its first quarter 2024 financial results conference call and webcast for 5:00 a.m. Pacific Time (8:00 a.m. Eastern Time) on May 1, 2024.

Corporate Presentation Link

OPEN WEBCAST